AREV announces major advancement in extraction scalability and throughput

Vancouver, British Columbia, April 24, 2019 – AREV Brands International Ltd. (“AREV” or the “Company”) (CSE – AREV) is pleased to announce that it has modified its sub critical “FFE”  Fast Freeze Extraction systems to be fully scaleable to handle tonnes of biomass on a continuous bases and has developed a patentable method that increases the ability to separate waxes from biomass on the fly.

AREV, a cannabis IP and integrator company through its strategic partnership with Alternative Extracts Inc. “AEI” is also pleased to announce today a strategic collaboration between the company and AEI., a leading extraction technology company in Surrey BC focused on projects working with materials including Ginseng, Sea Cucumber, Hemp, Frankincense, Agarwood, Turmeric and other exotic plant material from Asia. The collaboration involves information sharing and testing of various methods using different temperatures, pressure, flow rates, separations, solvents, gasses and vessels to produce high value oils with unique chemistry.  AEI has expertise and patents on bio similar cannabinoids from non-regulated sources and is working with AREV to apply this fractionation method to large scale cannabis and hemp biomass.

“We are pleased and have a sense of accomplishment in this advancement to the extraction capabilities we now have. We believe that this segment of our business has been overlooked by the investing public. Our capabilities in extraction have always been there and now with this advancement I am comfortable to say we have become a leader. This is another statement of our commitment to operate at the forefront of science and technology,” stated CEO Mike Withrow.


For further information, contact Mike Withrow, (778) 896-6536.

On behalf of the Board,


Mike Withrow
CEO & Director

About Alternative Extracts Inc. 

Alternative Extracts Inc. (AEI) is a biotechnology company specializing in advancing extraction methodologies and owns 7 patents related to immunology and bio-similar cannabinoids from non regulated sources. AEI sells and licenses its proprietary equipment and markets the high quality proprietary ingredients produced by its technology and proprietary equipment through its operating divisions and partnerships with supply chain leaders to medicinal, bioceutical, nutraceutical and cosmetic markets in North America and worldwide. AEI provides proprietary Fast Freeze Extraction (FFE) equipment to produce premium ingredients for the functional food, nutraceutical, bioceutical and natural health product sectors.The technology is clean, green, widely applicable and process scale. More is available at

About AREV Brands International Ltd. 
AREV Brands International Ltd. (“AREV”) produces and delivers functional compounds and ingredients from its world-class extraction systems. AREV is revolutionizing the current delivery method of terpenes, cannabinoids and flavonoids. These premium ingredients and formulations are used in products targeted for sale in the natural health, medical, functional food, nutraceutical, sport nutrition and bioceutical markets. AREV innovates through extraction to produce extracts from specific selected plant and exude from trees that address 5 areas of health including Anxiety, Pain Management, Insomnia, Central Nervous System Disorders & Libido. More information is available at



Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws. This press release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements.  Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company’s Management’s Discussion and Analysis under the Company’s profile on 

Presentation Request